已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Eight-year results of laser in-situ keratomileusis with or without combined accelerated cross-linking in highly myopic eyes

作者
Klemens Paul Kaiser,Jakob Wend,Petra Dávidová,Tyll Jandewerth,Zubeida H. Omerovic,Eva Hemkeppler,Christoph Lwowski,Myriam Böhm,Thomas Kohnen
出处
期刊:Journal of Cataract and Refractive Surgery [Lippincott Williams & Wilkins]
标识
DOI:10.1097/j.jcrs.0000000000001815
摘要

Purpose: To analyze the 8-year results of femtosecond laser-assisted-in-situ-keratomileusis (LASIK) combined with simultaneous accelerated corneal cross-linking (LASIK-Xtra) compared to conventional LASIK (convLASIK). Setting: Department of Ophthalmology, Goethe-University, Frankfurt, Germany. Design: A follow-up analysis of a prospective, randomized fellow eye-controlled clinical trial. Methods: Patients who received randomized treatment with the LASIK-Xtra (30mW/cm 2 , 90sec with continuous UVA) in one and convLASIK in the fellow eye were subjected preoperatively, 1 (pos1y) and 8 years postoperatively (pos8y) to subjective refraction, uncorrected (UDVA) and distance-corrected visual acuity (DCVA), endothelial cell count (ECC), biomechanical evaluation, and tomographic examination. Results: Twenty-six eyes (-7.07±1.86 diopter [D]) from 13 patients (mean age 30.7±10.4 years) were included. UDVA and DCVA were insignificant different at pos1y and pos8y between convLASIK and LASIK-Xtra (each p>0.28). Safety index at pos8y was 1.09 for convLASIK and 1.15 for LASIK-Xtra (p=0.799), and the efficacy index 0.91 and 0.94 (p=0.875), respectively. Significant myopic shift in spherical equivalent between pos1y (-0.30±0.40D) and pos8y (-0.80±0.86D) was found in the convLASIK group (p=0.018), compared the LASIK-Xtra group (-0.25±0.49D and -0.40±0.86D; p=0.261), respectively. However, these refractive changes cannot be fully attributed to corneal alterations alone and may also reflect other factors. Insignificant differences in mean keratometry, corneal thickness, and ECC were found at pos8y (p>0.05). Stress-strain index was the only biomechanical parameter that was significantly higher in the LASIK-Xtra group at pos8y (p=0.034). Conclusion: After 8 years, no substantial disparities in efficacy and safety indices were observed between the two groups. There were no substantial differences in most of the evaluated postoperative corneal biomechanical parameters between the two groups. However, these findings need to be validated by further studies with larger sample sizes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ayu完成签到 ,获得积分10
1秒前
2秒前
Iron_five完成签到 ,获得积分0
3秒前
hhq完成签到 ,获得积分10
4秒前
失眠魔镜发布了新的文献求助20
5秒前
Ayu关注了科研通微信公众号
7秒前
10秒前
10秒前
邱旭东发布了新的文献求助10
13秒前
小脸红扑扑完成签到 ,获得积分10
15秒前
21秒前
23秒前
平淡小鸭子完成签到,获得积分10
26秒前
27秒前
28秒前
30秒前
cc0803完成签到 ,获得积分10
32秒前
坤坤完成签到,获得积分10
32秒前
浮浮世世发布了新的文献求助10
35秒前
35秒前
祁风完成签到 ,获得积分10
35秒前
迅南发布了新的文献求助10
36秒前
特特雷珀萨努完成签到 ,获得积分10
39秒前
39秒前
42秒前
风清扬应助科研通管家采纳,获得10
43秒前
风清扬应助科研通管家采纳,获得30
43秒前
wanci应助科研通管家采纳,获得10
43秒前
我是老大应助科研通管家采纳,获得20
43秒前
酷波er应助科研通管家采纳,获得10
43秒前
43秒前
庄周完成签到,获得积分10
44秒前
Henvy完成签到,获得积分10
44秒前
Saven发布了新的文献求助10
46秒前
结实的忆之完成签到,获得积分20
47秒前
科研通AI6应助庄周采纳,获得10
48秒前
慕青应助Silver采纳,获得10
50秒前
一个爱打乒乓球的彪完成签到 ,获得积分10
50秒前
刘倩完成签到 ,获得积分10
51秒前
catch完成签到,获得积分10
52秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Hydrothermal Circulation and Seawater Chemistry: Links and Feedbacks 1200
A Half Century of the Sonogashira Reaction 1000
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
World Nuclear Fuel Report: Global Scenarios for Demand and Supply Availability 2025-2040 800
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 500
The Chemical Industry in Europe, 1850–1914 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5160090
求助须知:如何正确求助?哪些是违规求助? 4354299
关于积分的说明 13558178
捐赠科研通 4198301
什么是DOI,文献DOI怎么找? 2302465
邀请新用户注册赠送积分活动 1302575
关于科研通互助平台的介绍 1247849